标题
Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
作者
关键词
-
出版物
Journal of the American Heart Association
Volume 9, Issue 5, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2020-03-02
DOI
10.1161/jaha.119.014634
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General PopulationSignificance
- (2016) Alisa D. Kjaergaard et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Novel biomarkers with potential for cardiovascular risk reclassification
- (2016) Sagar Mallikethi-Reddy et al. BIOMARKERS
- Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial InfarctionClinical Perspective
- (2016) Erin A. Bohula et al. CIRCULATION
- From C-Reactive Protein to Interleukin-6 to Interleukin-1
- (2016) Paul M Ridker CIRCULATION RESEARCH
- Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases
- (2016) A. D. Kjaergaard et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Effect of serum YKL-40 on coronary collateral development and SYNTAX score in stable coronary artery disease
- (2016) Mehmet Kadri Akboga et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- BiomarkersSignificance
- (2015) Peter Libby et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Serum YKL-40 is increased in patients with slow coronary flow
- (2015) Ying Xu et al. CORONARY ARTERY DISEASE
- Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial
- (2015) Per Winkel et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Chitosan leads to downregulation of YKL-40 and inflammasome activation in human macrophages
- (2015) Steinunn Gudmundsdottir et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Elevated Plasma YKL-40, Lipids and Lipoproteins, and Ischemic Vascular Disease in the General Population
- (2015) Alisa D. Kjaergaard et al. STROKE
- Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial
- (2014) Erik Kjøller et al. AMERICAN HEART JOURNAL
- Anti-inflammatory therapies for cardiovascular disease
- (2014) P. M. Ridker et al. EUROPEAN HEART JOURNAL
- Net Risk Reclassification P Values: Valid or Misleading?
- (2014) Margaret S. Pepe et al. JNCI-Journal of the National Cancer Institute
- Plasma Levels of the Proinflammatory Chitin‐Binding Glycoprotein YKL‐40, Variation in the Chitinase 3‐Like 1 Gene ( CHI3L1 ), and Incident Cardiovascular Events
- (2014) Paul M Ridker et al. Journal of the American Heart Association
- Net Reclassification Indices for Evaluating Risk Prediction Instruments
- (2013) Kathleen F. Kerr et al. EPIDEMIOLOGY
- High-Sensitivity C-Reactive Protein and Cardiovascular Disease
- (2013) Omair Yousuf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: A prognostic study within the CLARICOR trial
- (2012) Marina Harutyunyan et al. IMMUNOBIOLOGY
- Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals
- (2012) Joseph Yeboah et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease
- (2012) Erik Kjoller et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
- (2012) Lesley A. Inker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Excess Sudden Cardiac Deaths after Short-Term Clarithromycin Administration in the CLARICOR Trial: Why Is This So, and Why Are Statins Protective
- (2011) Per Winkel et al. CARDIOLOGY
- Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease
- (2011) Anders B. Mathiasen et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- The Danish National Patient Register
- (2011) Elsebeth Lynge et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- The Danish Register of Causes of Death
- (2011) Karin Helweg-Larsen SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- NT-proBNP and Circulating Inflammation Markers in Prediction of a Normal Myocardial Scintigraphy in Patients with Symptoms of Coronary Artery Disease
- (2010) Camilla Noelle Rathcke et al. PLoS One
- Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction
- (2010) Anne Hedegaard et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial
- (2010) Marina J. Harutyunyan et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease
- (2009) Jian Lei Zheng et al. ATHEROSCLEROSIS
- Serum levels of YKL-40 increases in patients with acute myocardial infarction
- (2009) Camilla Nøjgaard et al. CORONARY ARTERY DISEASE
- High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease
- (2009) J. Kastrup et al. EUROPEAN HEART JOURNAL
- Clarithromycin for 2 Weeks for Stable Coronary Heart Disease: 6-Year Follow-Up of the CLARICOR Randomized Trial and Updated Meta-Analysis of Antibiotics for Coronary Heart Disease
- (2008) Christian Gluud et al. CARDIOLOGY
- General Cardiovascular Risk Profile for Use in Primary Care
- (2008) Ralph B. D’Agostino et al. CIRCULATION
- YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease
- (2008) Yongzhong Wang et al. SCANDINAVIAN CARDIOVASCULAR JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now